Evidence map›Paper›PMID 21269691›Full record

ArticleLeukemia research2011

Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.

Stephen M Akers, Stephanie L Rellick, James E Fortney, Laura F Gibson

Abstract read
In one paragraph

Article in Leukemia research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. The path to leptomeningeal metastasis.Nature reviews. Cancer · 2024
    Review
  6. Review
  7. Review
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stephen M AkersCancer Cell Biology Program, Robert C. Byrd Health Sciences Center, West Virginia University, School of Medicine, Morgantown, WV, USA.
Stephanie L Rellick
James E Fortney
Laura F Gibson
West Virginia University · US

Funding

THE ROLE OF HEF1 PROTEIN IN INVASION OF METASTATIC BREAST CANCERP20RR016440 · NCRR · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2001 to 2010
$22.8M
VCAM-1 Mediated Regulation of ES Cell DevelopmentR01HL056888 · NHLBI · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2002 to 2014
$4.0M
The Role of the Stem Cell Niche in ALLR01CA134573 · NCI · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2009 to 2013
$1.5M
BECTON-DICKINSON FACSARIA FLOW CYTOMETER: SARCOPENIAS10RR020866 · NCRR · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2006 to 2006
$425k
NCI NIH HHS R01 CA134573NCRR NIH HHS P20 RR016440NCRR NIH HHS S10 RR020866NHLBI NIH HHS R01 HL056888
6 · The paper itself

Abstract

CNS infiltration by leukemic cells remains a problematic disease manifestation of acute lymphoblastic leukemia (ALL). Prophylactic regimens for CNS leukemia including intrathecal chemotherapeutics have decreased CNS involvement in ALL, but are not without toxicities. Using co-culture models, we show that astrocytes, choroid plexus epithelial cells, and meningeal cells protect ALL cells from chemotherapy-induced cell death using drugs included in prophylactic regimens-cytarabine, dexamethasone, and methotrexate. Understanding how ALL cells survive in the CNS remains invaluable for designing strategies to prevent CNS leukemia and minimizing the need for treatment in this sensitive anatomical site where treatment-induced toxicity is of significant concern.

Indexed as

Antineoplastic AgentsAstrocytesCell CommunicationCell Line, TumorCells, CulturedCell SurvivalChoroid PlexusCoculture TechniquesCytarabineDexamethasoneDose-Response Relationship, DrugEpithelial CellsHumansMeningesMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsCytarabineDexamethasoneMethotrexate

Identifiers

PMID21269691
PMCPMC3099259
OpenAlexW2156213863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.